Overview
EMOTIV produces consumer and research-grade EEG headsets that enable brain-computer interaction, mental wellness monitoring, and cognitive performance tracking. Their EPOC and MN8 devices are widely used in academic research, workplace wellness, and adaptive technology applications.
EMOTIV is a neurotechnology company headquartered in San Francisco, California, that develops consumer and research-grade electroencephalography (EEG) headsets designed to make brain-computer interaction accessible at scale. The company's flagship products, including the EPOC series and the MN8 earbuds, capture real-time brainwave data to enable mental wellness monitoring, cognitive performance tracking, and adaptive technology applications. EMOTIV's hardware is paired with a proprietary software platform that processes and interprets neural signals, allowing users and researchers to derive actionable insights from brain activity. By combining wearable design with sophisticated signal processing, the company has worked to lower the technical and financial barriers traditionally associated with EEG-based neuroscience.
EMOTIV occupies a differentiated position in the neurofeedback market by serving both consumer and academic audiences simultaneously, giving it broad commercial reach across workplace wellness programs, clinical research institutions, and assistive technology developers. The company's devices have been adopted in thousands of peer-reviewed studies, establishing a credible scientific foundation that strengthens its standing with enterprise and institutional customers. Having raised funding through a Series B round, EMOTIV has demonstrated sustained investor confidence in its technology platform and business model. Its MN8 device, designed for unobtrusive workplace deployment, reflects the company's strategic push into the growing occupational health and cognitive performance monitoring sector.
EMOTIV matters to the neurotech industry because it has helped normalize EEG as a practical, deployable technology beyond the confines of traditional laboratory settings. By building a research-validated product ecosystem that scales from individual consumers to large organizations, the company has expanded the commercial surface area of applied neuroscience. Its work accelerates the broader industry's understanding of how continuous, passive brain monitoring can inform mental health, productivity, and human-machine interaction in everyday environments. As neurotech moves toward real-world integration, EMOTIV's combination of hardware accessibility, software infrastructure, and research credibility positions it as an important bridge between neuroscience and mainstream adoption.
More in Neurofeedback
Latest industry news
Synchron Closes $275M Series D to Accelerate Stentrode BCI Commercialization
2026-06-15 ยท Funding
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 ยท Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 ยท Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 ยท Industry
Company details
Category
๐ Neurofeedback
Location
San Francisco, CA, USA
Funding
Private ยท Series B
Website
emotiv.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages โ